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ABSTRACT 
 
[2.2.2]-Diazabicyclic alkaloids are a natural product family with diverse biological 
activities. The development of a synthetic methods towards the synthesis of 
[2.2.2]-diazabicyclic alkaloids is described.  
 
I: Diels-Alder Reactions of a C2-Carboxy Pyrazinone 
Using an N-heterocyclic carbene catalyzed aroylation of a proline 3,5-
dichloropyrazinone, a synthetic route to C2-carboxy pyrazinones was developed 
to study the intermolecular and intramolecular Diels-Alder reactions of these 
compounds to form the bicyclo[2.2.2]diazaoctane core. Studies showed that 
having oxidation present α to the pyrazinone ring did not provide any significant 
increase in reactivity or selectivity as compared to pyrazinones without oxidation 
α to the ring. In some cases, the oxidation completely hindered reactivity.   
 
II: Intermolecular Diels-Alder Reaction of a Proline Derived Pyrazinone with 
Symmetric Dienophiles 
The intermolecular Diels-Alder reaction of a proline derived pyrazinone with 
maleic anhydride allows for selective access the anti-C19 isomer of the [2.2.2]-
diazabicylic alkaloid. Selective opening of the resulting anhydride cycloadduct 
followed by radical excision of the C18 carboxy group provides a known 
intermediate in the Williams’ synthesis of Brevianamide B. The overall route 
provides the desired anti-C19 isomer of the methyl ester product in 6 steps and 
12% overall yield from the proline derived pyrazinone. This route constitutes a 15 
step formal synthesis of Brevianamide B.   
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Chapter 1: An Introduction to [2.2.2]-Diazabicyclic Alkaloids  
Overview of [2.2.2]-diazabicylic Alkaloids 
 Prenylated indole alkaloids containing a bicyclo[2.2.2]-diazaoctane core were first 
isolated in the late 1960’s as secondary metabolites from a number of fungal species.1,2,3,4 
The family now contains more than 10 different subgroups comprised of over 100 distinct 
members (Scheme 1). Many [2.2.2]-diazabicyclic alkaloids possess desirable biological 
activities including calmodulin inhibition, cytotoxicity, anthelmintic, and neuroprotection 
making them ideal natural product targets for synthetic chemists.1,5,6 The unique structure 
and diverse range of biological activities of [2.2.2]-diazabicyclic alkaloids have made them 
the subject of intense investigation since their discovery.7 
Scheme 1. Examples of various [2.2.2]-diazabicyclic natural products.  
Structurally, members of the family are formed of three parts: the eponymous 
bicyclo[2.2.2]-diazaoctane core, an amino acid derived cyclic portion, and a tryptophan 
moiety.1,7 The core piece is quite standard among most members of the family with the 
only variation being that some members possess a reduced monoketopiperazine core 
instead of the more common diketopiperazine form. The cyclic portion is most commonly 
a five-membered proline derived ring, however the marcfortine family of natural products 
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(including chrysogenamide A) possess a unique six-membered ring derived from pipecolic 
acid. Finally, the pendant tryptophan moiety is where the most variety exists between 
family members. Some contain halogenation (e.g. malbrancheamide B), while others have 
various prenyl derived substitution (e.g. stephacidin A and veriscolamide B).  
Members of the family can be further classified by the relative stereochemistry at 
C19 (brevianamide numbering) on the core. Namely, the hydrogen at this position possess 
either a syn- or anti-configuration with respect to the secondary lactam bridge.1 The less 
common anti-configuration has only been found in the breavianamide family and two other 
metabolites: chrysogenamide A and veriscolamide B.1  
Isolation and Biosynthesis 
The breavianamides were isolated by Birch and Wright in 1969 from Penicillium 
brevicopactum and were the first family of fungal secondary metabolites found to contain 
the bicyclo[2.2.2]-diazaoctane core.2 Since that first isolation, over 100 distinct alkaloids 
have been isolated containing the bicyclo[2.2.2]-diazaoctane core. Interestingly, it has 
been discovered that different fungal species can produce different enantiomers of the 
metabolites. For example, the marine fungus Aspergillus sp. MF297-2 produces (-)-
stephacidin A, whereas the terrestrial fungus Aspergillus versicolor produces its 
enantiomer (+)-stephacidin A.1, 8, 9, 10  
After isolating the breavianamides in 1969, Birch and co-workers conducting 13C-
labeled incorporation studies to investigate the biosynthetic pathways of the 
brevianamides.1,4 These studies initially revealed that brevianamide A is derived from L-
proline and L-tryptophan residues. Further analysis showed that the residues undergo a 
condensation to form cyclo-L-Trp-L-Pro which they called brevianamide F followed by a 
C2 reverse prenylation of the indole to give deoxybrevianamide E. Birch proposed that a 
subsequent oxidation and cyclization of deoxybrevianamide E would lead to brevianamide 
B. Using similar tracer incorporation studies, Williams and co-workers found that 
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deoxybrevianamide E does in fact undergo a stereosective indole oxidation.9,10 This is 
followed by another 2e- oxidation, intramolecular Diels-Alder (IMDA), and pinacol 
rearrangement to give brevianamide. Despite extensive efforts, the exact order of last 
three steps in the biosynthetic pathway has not been revealed. 
 
Scheme 2. Proposed biosynthetic pathway for the notoamides and stephacidins. 
Significant effort has been devoted by Williams and Sherman to investigating the 
biosynthetic pathways of the notoamides and stephacidins in different fungal species 
because of the discovery that different species produce different enantiomers.9,10 Genome 
sequencing and bioinformatic mining studies by Sherman isolated several gene clusters 
in the biosynthesis of the notoamides and stephacidins.9 Combined with biochemical 
studies, this enabled the development of an extensive biosynthetic pathway (Scheme 2).10 
They confirmed that the unique enantioselectivity observed in different fungal species was 
derived from an enantioselective IMDA reaction of an achiral pyrazinone precursor 
(Scheme 3).1 Although, the so-called Diels-Alderase enzyme has not been isolated all 
other evidence still supports that the entioselectivity is derived from a selective Diels-Alder 
reaction.  
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Scheme 3. Enantioselctive IMDA in the biosynthesis of stephacidin A.  
Synthetic Strategies Towards the Bicyclo[2.2.2]-diazaoctane Core 
 Several synthetic strategies have been developed to make the bicyclo[2.2.2]-
diazaoctane core en route to various natural products in the family including: (1) 
intramolecular SN2’ cyclization11,12 (2) biomimetic intramolecular Diels-Alder (IMDA) 
reaction7,13, (3) radical cyclization14, (4) oxidative enolate coupling15, (5) cationic 
cyclization cascade16,17,18, (6) Dieckmann condensation19, and (7) oxidative aza-Prins 
cyclization20.  
 The intramolecular SN2’ cyclization was developed by the Williams research group 
as a key method for the synthesis of a number of different prenylated indole alkaloid.7 Its 
first use in the synthesis of a [2.2.2]-diazabicyclic alkaloid came during the Williams 
groups’ synthesis of brevianamide B and again during their subsequent syntheses of 
paraherquamide B and stephacidin A (Scheme 4).11,12 During the synthesis of 
brevianamide B, synthesis of the key allylic chloride SN2’ cyclization precursor 2 from 
known allylated proline derivative 1 was followed by reaction with NaH in hot benzene with 
18-crown-6 added provided the desired epimer 3 of the [2.2.2]-diazabicylic core with anti-
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stereochemistry at C19 in a 4:1 ratio with the undesired syn-C19 epimer. 3 was then 
carried forward in 4 steps to give brevianamide B. A similar allylic chloride precursor 4 was 
used in the synthesis of paraherquamide B. Reaction of 4 with NaH in hot benzene without 
addition of 18-crown-6 provided the core scaffold 5 with exclusively syn-C19 
stereochemistry, as desired. 5 was then moved forward to paraherquamide B in 8 
additional steps.  
Scheme 4. Williams’ synthesis of brevianamide B and paraherquamide B featuring an intramolecular SN2’ 
cyclization. 
 After developing the intramolecular SN2’ cyclization method, the Williams group 
moved on to develop the biomimetic IMDA reaction to make the bicyclo[2.2.2]-diazaoctane 
core. The IMDA method was first used in the Williams groups’ biomimetic total synthesis 
of brevianamide B from biologically isolated epi-deoxybrevianamide E 6 in an effort to 
provide evidence for their proposed biosynthesis involving a biogenic Diels-Alder reaction 
(Scheme 5).13 Reaction of 6 with Me3OBF4 provided the lactim ether 7 which was then 
oxidized to the exocyclic unsaturated Diels-Alder precursor 8 upon reaction with DDQ. 
Treatment of 8 with aqueous KOH caused tautomerization to the pyrazinone azadiene 9, 
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which immediately underwent an IMDA to give 2:1 mix of diastereomers 10. Brevianamide 
B was synthesized by oxidation, pinacol rearrangement, and lactam hydrolysis of the 
minor isomer. Since its initial use, the IMDA method has been used in a number of racemic 
and asymmetric total syntheses of [2.2.2]-diazabicylic natural products.7  
Scheme 5. Williams’ synthesis of brevianamide B featuring a biomimetic IMDA reaction. 
While the biomimetic IMDA reaction developed by Williams and co-workers has 
arguably been the most widely used method for synthesis of the bicyclo[2.2.2]diazaoctane 
core, a number of other methods to synthesize the core have been developed in 
subsequent years. 
In their pursuit of stephacidin A, Myers and co-workers used a radical iminium 
cyclization to form the [2.2.2]-diazabicyclic core.14 Baran and co-workers developed an 
oxidative enolate coupling promoted by Fe(acac)3 to form the core during their synthesis 
of stephacidin A (Scheme 6).15 The cationic cyclization cascade was developed by 
Simpkins and co-workers in their asymmetric synthesis of (–)-malbrancheamide B.16 Their 
key precursor was a proline DKP with pendent indole and prenyl groups. Treatment of the 
precursor with TMS-OTf initially cleaves the Boc group from the indole nitrogen and 
subsequently promotes cyclization of the indole onto the prenyl group which then cyclizes 
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onto the DKP ring to establish both the bicyclo[2.2.2]-diazaoctane core and cyclohexene 
ring adjacent to the indole nucleus.   
Scheme 6. Asymmetric synthesis of stephacidin A by Baran and co-workers featuring an oxidative enolate 
coupling. 
More recently, the Sarpong group published their asymmetric synthesis of (+)-
stephacidin A (Scheme 7).19 Starting from precursor 11, the [2.2.2]-diazabicylic core 12 
was established from a Dieckmann condensation of the isocyanate-enolate intermediate 
13 formed from treatment of 11 with Dess-Martin periodinane followed by reaction with 
K2CO3. Wolff-Kishner reduction of the ketone group followed by reduction of the 
chromanone carbonyl group afforded (+)-stephacidin A. Additionally, they demonstrated 
that treatment of (+)-stephacidin A with excess MnO2 gave (+)-notoamide I which 
possesses a carbonyl at C10, adjacent to the [2.2.2]diazabicylic core. In 2016, notoamide 
I was the target of a synthesis by Sun, Li, and co-workers who established the core through 
an oxidative aza-Prins cyclization.20 This synthesis will be discussed in more detail in 
chapter 2 of this thesis.  
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Scheme 7. Synthesis of (+)-stephacidin A and (+)-notoamide I by Sarpong and co-workers featuring  
Conclusions 
 [2.2.2]-Diazabicyclic alkaloids represent a distinct class of natural products with a 
unique structural motif and diverse biological activities. Since the initial isolation of the 
brevianamides by Birch and Wright in 1969, a wide array of synthetic methods have been 
developed for the synthesis of the bicyclo[2.2.2]-diazaoctane core. Much room still exists 
to explore the use of Diels-Alder reactions to establish the [2.2.2]-diazabicyclic core and 
improve the stereoselectivity of such reactions. 
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Chapter 2: Diels-Alder Reactions of a C2-Carboxy Pyrazinone 
Introduction  
Between 2008 and 2010, Tsukamoto and co-workers published several articles on 
the isolation of several new prenylated indole alkaloids from the marine derived fungus 
Aspergillus sp. that possessed unique oxygenation at C10 (Scheme 1).21,22 These 
metabolites are members of the notoamide family of [2.2.2]-diazabicylic alkaloids and are 
related to the previously isolated alkaloid stephacidin A. It was later shown that 
notoamides F-H and notoamide R are downstream oxygenated metabolites of stephacidin 
A.1 For example, notoamides R possess a hydroxyl group at C10 and notoamide I is 
further oxidized possessing a carbonyl at C10. Alternatively, Stephacidin A and 
avrainvillamide are less oxidized at C10. Bioactivity assays conducted on the newly 
isolated metabolites showed that notoamide I is cytotoxic towards HeLa cells with an IC50 
value of 21 μg/mL.21 While this value is not as impressive as those of stephacidin A or the 
structurally related avrainvillamide which both possess impressive IC50 values of 1 μM and 
60 nM, respectively 
 
 
 
 
 
 
 
 
 
Scheme 1. Examples of [2.2.2]-diazabicyclic alkaloids with oxidation at C10.  
In 2016, Sun, Li, and co-workers published their synthesis of notoamides F, I, and 
R as well as the related spirocyclized alkaloid sclerotiamide (Scheme 2).20 To date, it 
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remains the only published method for synthesis of these oxidized [2.2.2]-diazabicyclic 
alkaloids. Their retrosynthetic plan was targeted at synthesizing notoamide I as it is the 
most oxidized at C10. They comment that their initial efforts to follow a similar pathway to 
the tandem radical cyclization methods developed by Simpkins and co-workers were met 
without success due to the unique C10 oxidation. This led them to develop a new method 
whereby the [2.2.2]-diazabicyclic core 2 is formed through an oxidative aza-Prins 
cyclization of DKP 1. The indole moiety was introduced using a Grignard reaction to give 
3. Cobalt-catalyzed radical cyclization of the indole onto the pendant isoprenyl group 
establishes the main scaffold followed by deprotection of the benzyl group on the indole 
with hydrogenation, copper-catalyzed propargylation and heating to afford notoamide I. 
Reduction of notoamide I with DIBAL-H gave (+)-notoamide R as a single stereoisomer 
followed by either acid catalyzed methanolysis to give (+)-notoamide F or pinacol  
rearrangement to give (-)-sclerotiamide.20  
 
Scheme 2. Sun, Li, and co-workers’ synthesis of notoamides I, R, and F and the spirocyclized sclerotiamide. 
Our work related to the synthesis of C10 oxidized [2.2.2]-diazabicyclic alkaloids, 
which began before Sun, Li, and co-workers had published their synthesis, was focused 
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on establishing the [2.2.2]-diazabicyclic core through the IMDA cyclization of a C2-carboxy 
DKP-azadiene with a pendant reverse prenyl dienophile. Our first goal was to develop a 
reliable synthetic path to the C2-carboxy DKP-azadiene IMDA precursor in order to 
evaluate if there is any inherent diastereoselectivity of the Diels-Alder when the C2-
carbonyl is present. After studying the intrinsic reactivity and selectivity of the C2-carboxy 
substrates, we hoped that having a carbonyl α to the DKP-azadiene would provide a 
handle to introduce some form of enantioselective catalysis to the Diels-Alder. In 
particular, Johnston and co-workers showed that their bis(amidine) (BAM) catalytic system 
was capable of inducing some control over enantioselectivity during the IMDA step of 
Williams’ synthesis of brevianamide (Scheme 3).23 We proposed that the additional C2-
carboxy group could provide a more attractive alternative binding site for the BAM catalyst. 
With these goals in mind, we began work on the synthesis of the desired C2-carboxy DKP-
azadiene IMDA precursor. 
 
 
 
 
 
 
 
Scheme 3. Enantioselective formation of the bicyclo[2.2.2]diazaoctane core of breavianamide by Johnston 
and co-workers using their H,Quin-BAMide catalyst.  
Retrosynthetic Plan 
 Cycloadduct 4 would provide a key scaffold which could be used in the synthesis 
of a number of [2.2.2]-diazabicyclic natural products. We proposed that 4 could arise 
through the IMDA of pyrazinone (DKP-azadiene) 5. In turn, pyrazinone 5 would be derived 
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from an oxidation/elimination cascade of C2-carbomethoxy DKP 6 which is synthesized 
from CBZ protected L-proline and dimethylaminomalonate (Scheme 4).24  
 
Scheme 4. Retrosynthetic plan for the synthesis of C10 oxidized cycloadduct 4.  
Synthesis of C2-carboxy Diketopiperazines 
 We started by synthesizing C2-carbomethoxy DKP 7 according to methods 
published by Trost and co-workers (Scheme 5).24 The HCl salt of dimethylamino malonate 
was coupled with N-Cbz proline to form amide 8. The Cbz group was removed by 
hydrogenation followed by heating in methanol to encourage intramolecular cyclization to 
C2-carbomethoxy DKP 7. The methyl ester of 7 was then hydrolyzed to carboxylic acid 9 
with LiOH, however 9 proved difficult to recover after aqueous work up and extraction 
resulting in detrimentally low yields. Instead, the methyl ester of 7 was transesterified to a 
benzyl ester in the presence of tributyltin oxide and BnOH. The benzyl group was then 
removed by hydrogenation to afford carboxylic acid 9 in good yield without need for an 
aqueous workup. The desired reverse prenylated ester 10 was formed through the 
coupling of 9 with 2-methyl-3-buten-2-ol in the presence of DCC. We also made allyl ester 
11 by transesterification of 7 with allyl alcohol to serve as a model system for developing 
an oxidation-elimination method to form the desired pyrazinone.  
13 
 
 
Scheme 5. Synthesis of C2-reverse prenyl ester 10 and C2-allyl ester 11.  
Oxidation-Elimination of DKP to Pyrazinone Azadiene 
 Initially, we explored known methods for the oxidation of a DKP to the pyrazinone 
tautomer with DDQ (Scheme 6). Williams and co-workers showed that DDQ could 
dehydrogenate an alkyl substituted lactim O-Me ether proline DKP 12 to give the exocyclic 
unsaturated product 13.25 The exocyclic product could then be easily isomerized in the 
presence of NaOH as a base to give pyrazinone 14. Additionally, our lab has shown that 
oxidation of DKP 15 with DDQ gives a 85:15 mixture of both the pyrazinone 16 and the 
exocyclic unsaturated product 17 without need for a second isomerization step.25 We were 
unsure whether oxidation of our model C2-allyl ester DKP with DDQ would directly yield 
the desired C2-allyl ester pyrazinone or a cycloadduct resulting from [4+2] cycloaddition 
with the pendent allyl group, but we were confident that the reaction would at least provide 
the exocyclic unsaturated product if it did not isomerize directly to the pyrazinone. 
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Scheme 6. Oxidation of various DKP rings with DDQ to provide pyrazinone azadienes.  
The reaction of C2-allyl ester DKP 11 with DDQ in refluxing toluene yielded an 
intractable mixture that did not appear to contain any of the possible desired products by 
1H NMR spectroscopic analysis. We surmised that the reaction did not work because DKP 
11 lacks the lactim O-Me ether functionality present in both of the example DKP oxidations. 
The lactim O-Me ether likely stabilizes the initial exocyclic unsaturated product before 
isomerization to the desired pyrazinone. We then attempted the DDQ oxidation again with 
BSA added to the reaction as well. Again, the reaction yielded a complex mixture of 
products, however, the 1H NMR spectrum of the mixture contained peaks characteristic of 
the desired [2.2.2]-diazabicyclic cycloadduct. However, when the mixture was purified by 
column chromatography none of the isolated compounds contained these characteristic 
cycloadduct peaks. Further reaction attempts again yielded complex mixtures which 
appeared to contain the desired cycloadduct, but the supposed cycloadduct was never 
isolated upon attempted purification by column chromatography.   
We then moved on to other oxidation-elimination methods to make the desired 
pyrazinone. First, we attempted to chlorinate the amide nitrogen of DKP 11 by reaction 
with t-BuOCl. However, the resulting N-chloro DKP product was not stable at room 
temperature or to column chromatography. Instead, we attempted to substitute a tosyl 
group onto the nitrogen by stirring with tosyl chloride in the presence of catalytic DMAP 
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according to a procedure published by Olenyuk and co-workers for the N-tosylation of a 
similar C2-carboxy DKP.27 After stirring for 3 days at room temperature no desired product 
was seen. In the same paper, Olenyuk and co-workers showed that it is possible to 
sulfenylate a C2-carboxy DKP at the C2 position using a number of triazole derived 
sulfenylation reagents (Scheme 7).26 This type of chemistry could work for our system as 
well because it constitutes a formal oxidation of the DKP ring, so we decided to try a 
modified sulfenylation reaction on DKP 11 as well as a newly synthesized β-ketone DKP 
18.  
 
 
 
 
Scheme 7. Example α-sulfenylation of a C2-carboxy DKP by Olenyuk and co-workers. 
α-Sulfenylation of C2-carboxy DKPs 
 Before we began trying the sulfenylation, we wanted to synthesize a C2-carboxy 
DKP with a lactim O-Me ether present to aid in formation of the desired C2-carboxy 
pyrazinone during the elimination step. Our lab has previously developed a method for the 
synthesis of C2 substituted pyrazinones using aldol chemistry. We extended this 
chemistry slightly by doing a Claisen condensation to form the desired C2-carboxy lactim 
O-Me ether DKP 18 from the reaction of ester 19 with proline derived DKP 20 (Scheme 
8). Interestingly, we found that 18 exists in the enol tautomer indicated by the presence of 
a singlet peak in the 1H-NMR far downfield at 13.4 ppm. This likely arises from the fact 
that 18 has a β-ketone functionality which is in contrast to the previous C2-carboxy DKP 
derivatives which have a β-ester functionality and do not display the downfield proton peak 
in their 1H-NMR spectra. 
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Scheme 8. Claisen condensation of ester 19 and DKP 20 to form C2-carboxy DKP 18 followed by α-
sulfenylation with N-(phenylthio)phthalimide. 
 Sulfenylation of 18 turned out to be quite easy to accomplish requiring a much less 
electrophilic sulfenylation reagent than what was used by Olenyuk and co-workers to 
sulfenylate their C2-carboxy ester DKP derivatives. Reaction of 18 with N-
(phenylthio)phthalimide in the presence of catalytic DBU provided the desired α-
sulfenylation product 21 without issue. A number of methods to eliminate the sulfenyl 
group and produce the desired C2-carboxy pyrazinone substrate were tried including: 
heating in base, reaction with various silver(I) salts, and heating in the presence of 2-
nitrophenol. None of the methods attempted provided the desired pyrazinone product or 
any cycloadducts which would result from an IMDA with the pyrazinone. Around the same 
time, we found a paper by Van der Eycken and co-workers on the NHC catalyzed 
aroylation of 3,5-dichloropyrazinones which could provide the desired C2-carboxy 
pyrazinones directly without need for the oxidation-elimination of a C2-carboxy DKP.  
NHC Catalyzed Aroylation of 3,5-Dichloropyrazinones as a Method to Synthesize 
C2-carboxy Pyrazinones 
 Diels-Alder and retro Diels-Alder reactions of 3,5-dichloropyrazinones have been 
explored previously as methods to access a number of biologically interesting natural 
product scaffolds.28 Despite this, there are no examples where a Diels-Alder with 3,5-
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dichloropyrazinone has been used in the synthesis of a [2.2.2]-diazabicyclic alkaloid 
natural product. A wide variety of methods have been published for functionalization of the 
C3 and C5 positions of 3,5-dihalopyrazinones.27 In particular, Van der Eycken and co-
workers developed an N-heterocyclic carbene catalyzed aroylation of the C3 position of 
3,5-dichloropyrazinones.28 Their method relies on the umpolung nature of the C3 position 
of 3,5-dihalopyrazinones to add in an NHC activated aldehyde to the C3 carbon followed 
by elimination of chlorine to reform the pyrazinone aromaticity. We proposed a synthesis 
whereby this method could be used with a proline derived 3,5-dichloropyrazinone 22 to 
access the C2-carboxy pyrazinone scaffold (Scheme 9). This method would completely 
side step the problematic DKP oxidation and elimination steps of our previously proposed 
methods to provide the desired azadiene which could then be used in a subsequent Diels-
Alder to form the [2.2.2]-diazabicyclic core.  
 
 
 
 
 
Scheme 9. Retrosynthetic plan for synthesis of C2-carboxy pyrazinones from 3,5-dichloropyrazinones. 
Synthesis of L-Proline Amino Nitrile  
 The synthesis of proline derived 3,5-dichloropyrazinone 22 was previously 
reported by De Borggraeve and co-workers from the reaction of L-prolinamide with oxalyl 
chloride and catalytic DMF.29 Although their procedure involved all commercially available 
starting materials, it had a poor yield of only 27% and a long reaction time of heating for 3 
days. More commonly, 3,5-dihalopyrazinones are synthesized through the reaction of 
substituted amino nitrile salts with oxalyl chloride. The majority of these methods have 
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higher reported yields ranging from 40-50%. Therefore, we decided to synthesize 22 from 
the corresponding L-proline amino nitrile salt 23 (Scheme 10).  
 
 
 
 
 
 
Scheme 10. Synthesis of the HCl salt of L-proline amino nitrile from N-Boc L-proline. 
Following known methods, commercially available N-Boc L-proline was stirred with 
ethyl chloroformate and NEt3 followed by addition of concentrated ammonium hydroxide 
to afford N-Boc L-prolinamide 24 which was then dehydrated in the presence of TFAA and 
NEt3 to give N-Boc L-proline amino nitrile 25. Boc deprotection of 25 with 4N HCl in 
dioxane yielded the HCl salt of L-proline amino nitrile 23.30,31 
Synthesis of Proline Derived 3,5-Dichloropyrazinone 
 With the amino nitrile precursor in hand, we began synthesis of the desired 3,5-
dichloropyrazinone 22. The first reaction of L-proline amino nitrile HCl salt 23 with oxalyl 
chloride resulted in a poor isolated yield (22% after purification) of 22. The HCl salt of 23 
was quite gummy and wet making it difficult to properly measure and add to the reaction. 
Coupled with its poor solubility in the reaction solvent, chlorobenzene, we surmised that 
this was likely the cause of the poor yield. Instead of using the HCl salt of 23, we made 
the TFA salt which could be recrystallized from ether to provide a much drier solid material 
that was easier to work with.32 After a number of trials (Table 1), varying reaction 
temperature and adding a catalytic amount of DMF one hour into the reaction, we were 
able to raise the isolated yield of 22 to a reasonable 45% which was comparable with other 
reported literature yields for the synthesis of 3,5-dichloropyrazinones.  
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Table 1. Trials for the cyclization of the TFA salt of 23 to 3,5-dichloropyrazinone 22.  
 
 
 
 
 
 
 
 
NHC Catalyzed Aroylation 
 Following Van der Eycken and co-workers’ procedure, 3,5 dichloropyrazinone 22 
was reacted with p-anisaldehyde in the presence of NHC catalyst 24 and NaH to give C2-
carboxy pyrazinone 25 for studying intermolecular Diels-Alder reactions. 22 was also 
reacted with aryl aldehyde 26 in the presence of NaH and 24 to give pyrazinone 27 for 
use in studying intramolecular Diels-Alder reactions (Scheme 11).  
 
 
 
 
 
 
 
 
 
 
 
Scheme 11. NHC catalyzed aroylation of 22 to give C2-carboxy pyrazinones.  
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We set about studying the relative propensity of pyrazinones 25 and 27 to undergo 
both intermolecular and intramolecular [4+2] cyclizations. 25 was reacted with a large 
excess of styrene to give a 3:2 mixture of diastereomers 28 and 29. This reactivity was 
not highly different than previously observed Diels-Alder reactions of pyrazinones in terms 
of selectivity. We attempted the reaction several more times with a number of Lewis acid 
additives, but none of the reactions provided any products resulting from cycloaddition 
(Table 2). Pyrazinone 27 was quite stable and did not readily undergo intramolecular 
cycloaddition at ambient temperatures. Heating 27 in refluxing toluene for 72 hours was 
also incapable of initiating cycloaddition. We hope to increase reactivity by converting the 
chlorine at C5 on the pyrazinone to a methoxy group with treatment of NaOMe to give 
pyrazinone 30. However again, heating of 30 in refluxing toluene provided no desired 
cycloaddition products (Scheme 12).  
Table 2. Intermolecular Diels-Alder reactions of pyrazinone 25 with styrene. 
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Scheme 12. Attempted IMDA reactions of C2-carboxy pyrazinones 27 and 30. 
Conclusions 
 The intermolecular Diels-Alder with a C2-carboxy pyrazinone did not provide any 
increase to the selectivity of the Diels-Alder reaction when compared to reactions with 
substrates lacking oxidation at C2. Furthermore, attempts to increase selectivity with the 
addition of various Lewis acids was met without success. The intramolecular Diels-Alder 
reaction was also unsuccessful. Heating at high temperatures failed to induce 
cycloaddition of pyrazinones 27 and 30, when similar compounds without the additional 
oxidation adjacent to the DKP ring are known to undergo cycloaddition at even ambient 
temperatures. These results coupled with the poor yields of reactions used to synthesized 
the C2-carboxy pyrazinone precursors led us to believe that further investigation would 
not provide meaningful results.  
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Chapter 3: Intermolecular Diels-Alder of a Pyrazinone with Symmetric Dienophiles  
Introduction 
 The use of an intermolecular Diels-Alder cycloaddition to form the bicyclo[2.2.2]-
diazaoctane core was explored previously by our lab.1 The [4+2] cycloaddition of a proline 
derived pyrazinone (azadiene) 1 with both achiral and chiral acrylate dienophiles permits 
rapid assembly of the [2.2.2]-diazabicylic core in a stereoselective fashion (Scheme 1).33 
The thermal [4+2] cycloaddition of ethyl acrylate and 1 resulted in a 3:1:1 mixture of regio- 
and stereoisomers with the major product 2 corresponding to cycloaddition from the endo 
transition state with the ethyl ester positioned distal to the indole nucleus of the 
pyrazinone. Furthermore, the reaction of 1 with a chiral dienophile, (+)-acryloyl camphor 
sultam, proved capable of inducing asymmetry in the cycloaddition providing a single 
diastereomer 3 (dr > 19:1) corresponding to cycloaddition from the endo transition state 
with the amide positioned distal to the indole of the pyrazinone. Both cycloadditions 
provide products with regiochemistry that does not easily permit extrapolation to natural 
products in the [2.2.2]-diazabicylic alkaloid family.    
 
 
 
 
 
 
 
 
 
Scheme 1. Racemic and enantio-enriched Diels-Alder cycloadditions of pyrazinone 1 with acrylate 
dienophiles.  
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In order to obtain the desired regioisomer with the carboxy group proximal to the 
indole nucleus, cycloaddition of 1 with methyl 2-nitroacrylate was performed. In the event, 
cycloaddition of 1 with the nitroacrylate dienophile provided the two regioisomeric 
products, 4 and 5, in a 4:1 ratio with the desired product being the major isomer (Scheme 
2). Both regioisomers were derived from cycloadditions where the nitro group is positioned 
endo in the cycloaddition transition state. However, the two regioisomers proved difficult 
to separate by column chromatography, and attempts to remove the nitro group resulted 
in elimination rather than direct reduction. Instead, it became more operationally simple to 
induce elimination of the nitro group with DBU and separate the two resulting unsaturated 
ester products by column chromatography. Attempted stereoselective hydrogenation of 5 
with various catalysts such as Crabtree’s catalyst and Striker’s reagent under various 
reaction conditions gave limited success. Hydrogenation of unsaturated ester 6 with Pd/C 
resulted in a 1:1 mix of anti- and syn-fused C19 isomers, 7 and 8. The two isomers were 
separated and carried forward in two separate routes to intercept known intermediates in 
the Williams synthesis of brevianamide B (anti-fused isomer 7) and the Baran synthesis 
of premalbrancheamide (syn-fused isomer 8).  
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Scheme 2. Diels-Alder cycloaddition of pyrazinone 1 with 2-nitroacrylate to intercept known 
intermediates from two separate syntheses of bicyclo[2.2.2]diazaoctane alkaloids by Baran and 
Williams.  
 
Overall, the route provided efficient entry to the bicyclo[2.2.2]diazaoctane core 
(four to five steps from proline methyl ester) and gave useful insight into the intermolecular 
Diels-Alder of pyrazinone 1 with a number of acrylate derived dienophiles. It demonstrated 
that the [4+2] cycloaddition is most favorable with electron deficient substrates. The more 
electron withdrawing substituent on the dienophile adds distal to the indole nucleus in an 
endo fashion. This was exploited in the cycloaddition with nitroacrylate to obtain the 
desired regeiochemistry with the methyl ester positioned proximal to the indole nucleus. 
The route has a few limitations. Mainly, the Diels-Alder is not particularly selective 
providing a 4:1 mix of products, the nitroacrylate dienophile is not commercially available 
and must be synthesized in 3 steps from methyl acrylate, and the hydrogenation of the 
unsaturated methyl ester 6 is entirely unselective affording a 1:1 mix of anti- and syn-fused 
products. With these limitations in mind, we sought to explore the intermolecular Diels-
Alder cycloadditions of commercially available symmetric dienophiles with pyrazinone 1 
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with the goal of developing separate synthetic routes to the anti- and syn-fused methyl 
ester products, 7 and 8.  
Developing Separate Routes to the syn- and anti-C19 Isomers  
 When thinking about developing separate synthetic routes to the anti- and syn-
C19 isomer, we proposed that the use of symmetric electron deficient dienophiles would 
limit the number of possible regio- and stereoisomeric products of the Diels-Alder 
reactions when compared to the acrylate derived dienophiles. We envisioned that the syn-
C19 isomer could be derived from the Diels-Alder reaction of pyrazinone 1 with dimethyl 
fumarate based on the selectivity of the nitroacrylate reactions. Selective hydrolysis of the 
methyl ester at C18 followed by excision of the resulting carboxy group using radical 
decarboxylation would give the syn methyl ester product 8. Similarly, we proposed that 
the [4+2] cycloaddition of 1 with maleic anhydride would likely give the endo cycloadduct 
as the major product which would establish the desired anti-C19 stereochemistry. The 
desired anti methyl ester product 7 would then be achieved through selective anhydride 
opening and excision of the C18 carboxy group (Scheme 3).  
Scheme 3. Proposed synthetic routes to anti- and syn-C19 isomers.  
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Intermolecular Diels-Alder with Dimethyl Fumarate 
The [4+2] cycloaddition of 1 with dimethyl fumarate proceeded readily at room 
temperature and yielded a single diastereomer 9 (dr > 20:1 as judged by 1H NMR of the 
unpurified reaction) (Scheme 4). The unpurified reaction mixture was quite clean, 
containing only desired product and excess dimethyl fumarate. Using NOESY NMR 
spectroscopy, we initially determined that 9 possessed the syn-fused stereochemistry at 
C19. This result was in agreement with previous results wherein the group at C18 is 
oriented endo in the Diels-Alder transition state to push it as far from the pendant indole 
as possible. Surprisingly, the stereoselectivity for the major product with dimethyl fumarate 
was much higher than with either of the two acrylate derived dienophiles (i.e. dr > 20:1 
with dimethyl fumarate vs dr = 4:1 with nitroacrylate). The absolute stereochemistry of 9 
was confirmed from an X-ray crystal structure of the lactam product 10 obtained from 
hydrolysis of 9 with TsOH and H2O to give the open chain tautomer of the lactim O-methyl 
ether followed by recyclization to the lactam.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 4. [4+2] cycloaddition of pyrazinone 1 with dimethyl fumarate followed by hydrolysis of 
lactim O-methyl ether 9 to give lactam cycloadduct 10. 
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Selective Hydrolysis of the Dimethyl Fumarate Cycloadduct 
With structure of the dimethyl fumarate cycloadduct determined by X-ray 
crystallography, we began work on the selective hydrolysis of the methyl ester at C18 to 
provide a carboxylic acid which could be removed by radical decarboxylation (Scheme 5). 
It was shown previously that monohydrolysis of bicyclo[2.2.1]heptane-2,3-dicarboxylate 
derivatives with LiOH or KOH is highly selective for the exo ester.34 We found that 
hydrolysis of 10 with LiOH·H2O (1.05 equivalents) stirring at 0 °C for 18 hours gave only 
the bishydrolysis product and unreacted starting material. We then turned to tin mediated 
transesterification and hydrolysis methods with the hope that the bulkier tin reagents would 
be able to provide some selectivity.  
First, we attempted tin mediated transesterification, pioneered by Otera, by stirring 
10 and BnOH in the presence of catalytic bis(tri-n-butyl tin) oxide in refluxing toluene for 
24 hours.35 The reaction afforded only the doubly transesterified product with no apparent 
selectivity. Nicolaou and co-workers showed that selective hydrolysis of a wide variety of 
methyl esters could be achieved using trimethyltin hydroxide.36 Reaction of 10 with 
trimethyltin hydroxide in refluxing 1,2-dichloroethane provided a 1:1 mix of monohydrolysis 
products with no apparent selectivity. While the methods we attempted did not appear to 
provide selective hydrolysis, it is by no means exhaustive and there are certainly other 
methods that could provide selectivity, but we decided to focus more heavily on the 
reaction of 1 with maleic anhydride.  
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Scheme 5. Attempted methods for selective monohydrolysis and transesterification of dimethyl 
fumarate cycloadduct 10.  
 
Intermolecular Diels-Alder with Maleic Anhydride  
 The intermolecular Diels-Alder of maleic anhydride with pyrazinone 1 could provide 
only two possible diastereomeric products. We surmised that the major product would 
likely be the product derived from the endo transition state providing the desired anit-fused 
stereochemistry at C19. When conducted, the [4+2] cycloaddition of maleic anhydride with 
pyrazinone 1 proceeded smoothly at room temperature yielding an 8:1 (endo:exo) mix of 
cycloadducts 11 and 12 as determined by 1H-NMR analysis of the unpurified reaction 
mixture (Scheme 6). Cooling the reaction to -20 °C did not provide any change in 
selectivity, however heating the reaction at 50 °C decreased selectivity from 8:1 to 6:1 
(endo:exo). The two isomers were easily separated by column chromatography providing 
the desired endo isomer 11. To obtain the desired methyl ester product 7, we needed to 
selectively open the anhydride cycloadduct with an appropriate nucleophile and 
selectively excise the carboxyl group at C18.  
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Scheme 6. Diels-Alder cycloaddition of pyrazinone 1 with maleic anhydride. 
Selective Opening of Malic Anhydride Cycloadduct 
 In order to determine if there was any inherent selectivity for opening the anhydride 
of the cycloadduct, we reacted cycloadduct 11 with methanol in the presence of DMAP. 
The reaction provided a 1:6 mix of mono-methyl ester products. Upon purification of the 
reaction mixture by flash column chromatography, both products degraded and were not 
recovered after being loaded onto the column. We suspected that the acid sensitive lactim 
O-methyl ether functionality was being hydrolyzed by the carboxylic acid formed during 
the anhydride opening. The lactim O-methyl ether hydrolysis product would be highly polar 
because of its Zwitter-ionic nature and not likely to come off the column with the conditions 
used. We overcame this problem by doing an in situ protection of the carboxylic acid with 
benzyl bromide after opening the anhydride cycloadduct 11 with methanol. The resulting 
products were then stable to column chromatography and were isolated in a 1:9 mix 
(Scheme 7).  
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Scheme 7. Selective nucleophilic opening of maleic anhydride cycloadduct 11 followed by in situ 
protection of the resulting carboxylic acid.  
 
Using 2D-NMR we were able to determine that the major product had the methyl 
ester at C18 and the benzyl ester at C19 resulting from selective nucleophilic attack of the 
methanol at the anhydride carbonyl distal to the indole moiety. This provided the wrong 
regiochemistry for the resulting esters, as we wanted the methyl ester at C19 and the 
benzyl ester at C18. To obtain the desired regiochemistry, we instead opened the 
anhydride cycloadduct 11 with benzyl alcohol followed by in situ protection of the resulting 
carboxylic acid with methyl iodide affording a 6:1 mix of the desired and undesired 
regioisomers, 13 and 14. Unfortunately, the sequence was plagued by a poor overall yield 
(< 30% over the two steps), so we sought to improve the yield by changing the electrophilic 
methylation reagent. Instead of methyl iodide we used TMS diazaomethane as the 
methylation reagent. The reaction still provided the desired product, but the yield of 26% 
over two steps was still quiet poor. Opening the anhydride at –78 °C with the more 
nucleophilic lithiated benzyl alcohol provided the desired product with an improved yield 
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of 49% and slightly improved selectivity of 7:1 for the desired regioisomer 13. Hydrolysis 
of the lactim O-methyl ether functionality of 13 with TsOH·H2O and recyclization provided 
lactam 15 in high yield. Simple deprotection of the benzyl ester at C18 by hydrogenation 
provided the carboxylic acid precursor 16 necessary for radical decarboxylation (Scheme 
8).  
 
 
 
 
Scheme 8. Conversion of the lactim O-methyl ether 13 to lactam 15 by hydrolysis and recyclization 
followed by deprotection of the benzyl ester at C18 to give carboxylic acid 16. 
 
Radical Decarboxylation to Obtain the Anti-fused Methyl Ester  
  Since Barton and co-workers published their seminal works on the eponymous 
Barton decarboxylation reaction in 1962 and 1980, methods for radical decarboxylation 
have been both widely used and improved upon to convert carboxylic acids into many 
other functional groups.37,38,39 The original Barton decarboxylation protocol involved 
converting the carboxylic acid into an acid chloride followed by addition of 2-
mercaptopyridine N-oxide to form a thiohydroxamate ester. The N-O bond of the 
thiohydroxamate ester is prone to homolytic bond cleavage. When heated in the presence 
of the radical initiator AIBN and a hydrogen donor such as tri-n-butyltin hydride, the ester 
undergoes radical bond cleavage, decarboxylation, and a radical hydride transfer to give 
the decarboxylated hydrocarbon product.  
Modern methods have replaced the highly toxic tri-n-butyltin hydride with less toxic 
reductive hydride donors such as t-butyl thiol. In the early 1980s, Okada and co-workers 
published several articles demonstrating that N-hydroxy phthalimide derived esters were 
also capable of undergoing homolytic bond cleavage and decarboxylation to form alkyl 
radicals which they then reacted with hydride donors to form hydrocarbons or diphenyl 
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diselenide to form alkyl selenides.40,41 They also demonstrated that homolytic N-O bond 
cleavage of the phthalimodyl esters could be initiated using a variety of methods including: 
heating in the presence of AIBN (1) and photocatalytic initiation with both organic and 
inorganic photocatalysts (2). More recently, Nicewicz and co-workers have developed a 
catalytic hydrodecarboxylation method which uses an organic photocatalyst to directly 
convert carboxylic acids to hydrocarbons.42 
 While attempting the Barton decarboxylation method on a model system derived 
from the opening of 1,2-cyclohexane dicarboxylic anhydride, we found that the Barton 
ester could be formed in good yields by doing an EDC coupling of the carboxylic acid 
precursor with 2-mercaptopyrine N-oxide. We also discovered that the resulting Barton 
ester was light sensitive, and the use of column chromatography for purification resulted 
in diminished yield of pure product and isolation of an undesired by-product resulting from 
decarboxylation of the ester and recombination of the resulting alkyl radical with the 
thiopyridine radical produced from the initial N-O bond cleavage. Therefore, when working 
with our actual decarboxylation substrate 16, we decided to attempt making both the 
thiohydroxamate and phthalimidoyl esters for decarboxylation. We surmised that the 
phthalimidoyl ester would be more stable to light and heat than the thiohydroxamate ester, 
and could therefore likely be purified and isolated by column chromatography without 
issue.  
 As predicted, the EDC coupling of carboxylic acid 16 with 2-mercaptopyridine N-
oxide yielded a mix of products that was light sensitive and not stable to purification by 
column chromatography. On the other hand, the coupling of acid 16 with N-hydroxy 
phthalimide provided the desired ester 17 in good yield, and the product was easily purified 
to remove excess N-hydroxy phthalimide and EDC related compounds. Following the 
protocol from Okada and co-workers, we first attempted a photocatalyzed decarboxylation 
by stirring ester 17 under blue LEDs in the presence of a Hantzsch ester (diethyl-1,4-
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dihydro-2,6-dimethyl-3,5-pyridine dicarboxylate), t-BuSH, 10 mol% of Ru(bpy)3Cl2·6H2O 
using a 7:3 mix of THF:H2O as the solvent. After stirring at room temperature for 24 hours, 
the reaction resulted in only recovered starting material and a by-product resulting from 
hydrolysis of the ester back to the carboxylic acid in the presence of water. The 
photocatalyzed decarboxylation was attempted once more using CH3CN as a solvent 
instead of a THF:H2O mixture, but it resulted in a mixture of products which did not appear 
to contain the desired methyl ester product. Clean decarboxylation of ester 17 to afford 
the desired anti-fused methyl ester 18 was finally achieved by heating in the presence of 
AIBN, Hantzsch ester, and t-BuSH using CH3CN as a solvent (Scheme 9).  
 
Scheme 9. EDC coupling of carboxylic acid 16 with N-hydroxy phthalimide to form phthalimidoyl ester 17, 
followed by radical decarboxylation to afford the desired anti-fused C19 methyl ester 18.  
 
Conclusions 
 The structure of 18 was confirmed by making 18 using the methods described in 
the previous synthesis using nitroacrylate as the dienophile (i.e., hydrogenation of the 
unsaturated methyl ester cycloadduct followed by lactam hydrolysis of the two isomer and 
separation by column chromatography).33 Our overall route to the anti-C19 stereoisomer 
of methyl ester [2.2.2]-diazabicyclic alkaloid 18 takes 6 steps from proline derived DKP 1 
with an overall yield of 12%. 18 is a known compound that is 3 steps from an intermediate 
in the Williams’ synthesis of brevianamide B constituting a 15 step formal synthesis 
(longest linear route). The route improves upon the previous synthesis by our group, as it 
provides only a single stereoisomer at C19 instead of a 1:1 mix of anti:syn stereoisomers. 
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Additionally, the starting maleic anhydride dienophile is commercially available and does 
not have to synthesized, unlike the nitroacrylate dienophile which requires 3 steps that are 
not particularly easy to accomplish. Although, the yields of the two routes are comparable 
the new route is an improvement in overall steps and the fact that it uses a commercially 
available dienophile.  
Experimental 
General Information 
Unless otherwise noted, all reactions were carried out in flame-dried or oven-dried 
glassware under an atmosphere of nitrogen with magnetic stirring. THF, toluene, and 
acetonitrile were degassed with argon and dried by passage through a column of 
molecular sieves and a bed of activated alumina. Dichloromethane was distilled from CaH2 
prior to use. All reagents were used as received unless otherwise noted. Flash column 
chromatography was performed using SiliCycle siliaflash P60 silica gel (230-400 mesh). 
Analytical thin layer chromatography was performed on SiliCycle 60Å glass plates. 
Visualization was accomplished with UV light, ceric ammonium molybdate, potassium 
permanganate, or ninhydrin, followed by heating. Film infrared spectra were recorded 
using a Digilab FTS 7000 FTIR spectrophotometer. 1H NMR spectra were recorded on an 
A400b Agilent DD2 NMR (400 MHz) spectrometer and are reported in ppm using solvent 
as an internal standard (CDCl3 at 7.26 ppm) or TMS (0.00 ppm). Proton-decoupled 13C 
NMR spectra were recorded on an A400b Agilent DD2 NMR (100 MHz) spectrometer and 
are reported in ppm using solvent as an internal standard (CDCl3 at 77.00 ppm). All 
compounds were judged to be homogeneous (>95% purity) by 1H and 13C NMR 
spectroscopy. Mass spectra data analysis was obtained through positive electrospray 
ionization (w/ NaCl) on a Bruker 12 Tesla APEX-Qe FTICR-MS with an Apollo II ion 
source.  
*All compounds listed were isolated as racemic mixtures.  
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Experimental Procedures 
 
Dimethyl (6R*,7R*,8R*,8aR*)-6-((1-(tert-butoxycarbonyl)-1H-indol-3-yl)methyl)-9-
methoxy-5-oxo-2,3,5,6,7,8-hexahydro-1H-6,8a-(azenometheno)indolizine-7,8-
dicarboxylate. (9) 
A dry flask was charged with pyrazinone 1 (200 mg, 0.51 mmol) and dimethyl fumarate 
(146 mg, 1.01 mmol). The reaction flask was then flushed with N2 gas for 10 min before 
toluene (5 mL) was added and the vessel evacuated to 40 torr for 5 min and backfilled 
with N2 gas. The reaction flask was covered in foil to keep out ambient light, and the 
reaction stirred at rt for 16 h.  The solution was concentrated in vacuo to afford a yellow 
oil, which contained a single cycloadduct 9 (dr > 20:1 as judged by 1H NMR of the 
unpurified reaction mixture) and excess dimethyl fumarate. The resulting residue was 
purified by flash column chromatography on silica gel (gradient elution: 20% → 100% 
EtOAc in hexanes) to afford cycloadduct 9 as a yellow oil (240 mg, 88% yield): TLC (60% 
EtOAc in hexanes), Rf: 0.28 (UV, CAM); IR (film, cm-1) 2986, 2948, 1729, 1685, 1638, 
1450, 1367, 1308, 1256, 1155, 1082, 1015, 745; 1H NMR (400 MHz, CDCl3) δ 8.10 (d, J= 
8.3 Hz, 1H), 7.77 (dd, J= 7 Hz, 0.9 Hz, 1H), 7.74 (s, 1H), 7.27 (td, J= 7.5 Hz, 1.2 Hz, 1H), 
7.19 (td, J= 7.8 Hz, 1.2 Hz, 1H), 3.72 (s, 3H), 3.71 (s, 3H), 3.64 (s, 3H), 3.56 (m, 1H), 3.51 
(m, 1H), 3.49 (d, J= 15.2 Hz, 1H), 3.26 (d, J= 15.2 Hz, 1H), 3.16 (d, J= 5.5 Hz, 1H), 3.03 
(d, J= 5.5 Hz, 1H), 2.62 (m, 1H), 2.05 (m, 2H), 1.95 (m, 1H), 1.66 (s, 9H); 13C NMR (400 
MHz, CDCl3) δ 171.5, 170.8, 170.6, 169.5, 149.9, 132.2, 125.6, 123.8, 121.8, 120.8, 116.0, 
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114.8, 83.1, 68.5, 64.8, 54.9, 52.9, 52.5, 50.0, 43.5, 28.2, 28.1, 28.1, 27.1, 24.5; MASS 
SPEC SAMPLE NEEDS TO BE SUBMITTED. 
 
Dimethyl (6S*,7R*,8R*,8aS*)-6-((1-(tert-butoxycarbonyl)-1H-indol-3-yl)methyl)-5,9-
dioxohexahydro-1H-6,8a-(epiminomethano)indolizine-7,8-dicarboxylate. (10) 
A dry flask was charged with cycloadduct 9 (275 mg, 0.51 mmol) and flushed with N2 gas 
for 10 min, dissolved in CH2Cl2 (5 mL), and cooled to 0 °C. To the reaction flask was added 
pTsOH·H2O (115 mg, 0.61 mmol), and the reaction was stirred for 2 h at 0 °C. The reaction 
mixture was diluted with sat’d aq NaHCO3 (10 mL) and extracted with CH2Cl2 (4 X 10 mL). 
The combined organic layers were washed with sat’d aq NaCl (50 mL), dried with 
anhydrous Na2SO4, filtered, and concentrated in vacuo. The resulting product was 
dissolved in toluene (5 mL) and stirred at 80 °C for 18 h. The solution was concentrated 
in vacuo to afford lactam 10 as a white solid. The unpurified reaction mixture was purified 
by flash column chromatography on silica gel (gradient elution: 40% → 100% EtOAc in 
hexanes) to afford lactam 10 as a pale yellow solid (250 mg, 94% yield): TLC (60% EtOAc 
in hexanes) Rf: 0.28 (UV, CAM); m.p. 96.8-97.9 °C; IR (film, cm-1) 3218, 3116, 2953, 2252, 
1723, 1695, 1450, 1387, 1361, 1310, 1255, 1205, 1158, 1095, 1003, 911, 852, 724, 645; 
1H NMR (400 MHz, CDCl3) δ 8.15 (d, J= 8.2 Hz, 1H), 7.73 (s, 1H), 7.60 (d, J= 8.2 Hz, 1H), 
7.36 (td, J= 8.2 Hz, 1.2 Hz, 1H), 7.28 (td, J= 7.4 Hz, 1.2 Hz, 1H), 5.85 (s, 1H), 3.83 (s, 3H), 
3.71 (s, 3H), 3.69 (d, J= 5.3 Hz, 1H), 3.61 (d, J= 15.6 Hz, 1H), 3.61 (m, 1H), 3.58 (m, 1H), 
3.44 (d, J= 4.7 Hz, 1H), 3.20 (d, J= 15.7 Hz, 1H), 2.75 (m, 1H), 2.09 (m, 2H), 1.98 (m, 1H), 
1.69 (s, 9H); 13C NMR (400 MHz, CDCl3) δ 170.4, 169.8, 169.5, 166.3, 149.4, 135.3, 130.7, 
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126.3, 125.0, 123.2, 118.2, 115.6, 112.0, 84.0, 68.0, 62.9, 53.0, 52.9, 52.4, 51.7, 44.3, 
28.5, 28.1, 24.3, 24.1; exact mass calc’d for C27H31N3O8Na [M + Na]+ 548.2003, found 
548.2006. A single crystal of 10 was obtained by evaporation from Et2O and its structure 
was determined by X-Ray crystallographic analysis.  
 
tert-Butyl 3-(((3aS*,4R*,9aR*,9bR*)-10-methoxy-1,3,5-trioxo-1,3,3a,8,9,9b-
hexahydro-7H-4,9a-(azenometheno)furo[3,4-g]indolizin-4(5H)-yl)methyl)-1H-indole-
1-carboxylate (11) and Tert-butyl 3-(((3aR*,4R*,9aR*,9bS*)-10-methoxy-1,3,5-trioxo-
1,3,3a,8,9,9b-hexahydro-7H-4,9a-(azenometheno)furo[3,4-g]indolizin-4(5H)-
yl)methyl)-1H-indole-1-carboxylate. (12) 
A dry flask was charged with pyrazinone 1 (200 mg, 0.51 mmol) and maleic anhydride (98 
mg, 1.01 mmol) and flushed with N2 gas for 10 min, cooled to –20 °C, dissolved in toluene 
(10 mL), evacuated to 40 torr for 5 min, and backfilled with N2 gas. The reaction flask was 
covered in foil to keep out ambient light, and the reaction stirred and allowed to warm to 
ambient temperature over 16 h. The solution was concentrated in vacuo to give a pale 
yellow solid containing the two diastereomeric cycloadducts 11 and 12 in an 8:1 ratio (as 
judged by 1H NMR of the unpurified reaction mixture). The mixture was purified by flash 
column chromatography on silica gel (gradient elution: 20% → 100% EtOAc in hexanes) 
to afford pure 11 (144 mg, 58% yield) and 12 (18 mg, 7% yield) as pale yellow solids: 11: 
TLC (60% EtOAc in hexanes) Rf: 0.23 (UV, CAM); m.p. 126.4-128.2 °C; IR(film, cm-1) 
2981, 1865, 1781, 1688, 1631, 1450, 1368, 1252, 1216, 1155, 1076, 917, 727; 1H NMR 
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(400 MHz, CDCl3) δ 8.06 (d, J= 7 Hz, 1H), 7.83 (dd, J= 7 Hz, 1.6 Hz, 1H), 7.74 (s, 1H), 
7.26 (td, J= 7.1 Hz, 1.6 Hz, 1H), 7.23 (td, J= 7.4 Hz, 1.6 Hz, 1H), 3.88 (dd, J= 14.5 Hz, 0.8 
Hz, 1H), 3.70 (s, 3H), 3.62 (d, J= 14.5 Hz, 1H), 3.60 (d, J= 8.6 Hz, 1H), 3.45 (m, 1H), 3.38 
(d, J= 8.2 Hz, 1H), 3.35 (m, 1H), 2.68 (dt, J= 14.1 Hz, 7.4 Hz, 1H), 2.48 (dt, J= 14.1 Hz, 
7.1 Hz, 1H), 2.03 (m, 2H), 1.67 (s, 9H); 13C NMR (400 MHz, CDCl3) δ 169.5, 168.3, 167.6, 
167.2, 149.9, 134.8, 132.0, 126.2, 123.8, 122.0, 120.7, 116.0, 114.8, 83.2, 69.2, 65.4, 
55.4, 51.2, 47.6, 43.9, 28.2, 27.2, 25.7, 23.9; exact mass calc’d for C26H24N3O7Na [M + 
Na]+ 516.1741, found 516.1740. 12: TLC (60% EtOAc in hexanes) Rf: 0.33UV, CAM); m.p. 
114.3-115.5 °C; IR (film, cm-1) 2977, 1870, 1780, 1683, 1631, 1451, 1368, 1254, 1217, 
1154, 1076, 920, 728; 1H NMR (400 MHz, CDCl3) δ 8.12 (d, J= 7.8 Hz, 1H), 7.96 (d, J= 
7.5 Hz, 1H), 7.79 (s, 1H), 7.29 (td, J= 7.8 Hz, 1.2 Hz, 1H), 7.21 (td, J=7.5 Hz, 0.9 Hz, 1H), 
3.76 (d, J= 14.8 Hz, 1H), 3.76 (s, 3H), 3.59 (m, 1H), 3.57 (d, J= 15.3 Hz, 1H), 3.45 (d, J= 
9.4 Hz, 1H), 3.29 (m, 1H), 3.12 (d, J= 9.4 Hz, 1H), 2.69 (m, 2H), 2.11 (m, 1H), 1.89 (m, 
1H), 1.65 (s, 9H); 3C NMR (400 MHz, CDCl3) δ 171.8, 169.2, 167.8, 167.0, 149.7, 136.4, 
131.7, 131.7, 126.1, 124.1, 122.0, 121.2, 115.3, 114.8, 83.5, 68.3, 65.8, 55.6, 48.0, 47.6, 
44.4, 28.1, 26.0, 25.1, 24.6; exact mass calc’d for C26H24N3O7Na [M + Na]+ 516.1741, 
found 516.1738. 
 
8-Benzyl 7-methyl (6R*,7R*,8S*,8aR*)-6-((1-(tert-butoxycarbonyl)-1H-indol-3-
yl)methyl)-9-methoxy-5-oxo-2,3,5,6,7,8-hexahydro-1H-6,8a-
(azenometheno)indolizine-7,8-dicarboxylate (13) and 7-Benzyl 8-methyl 
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(6R*,7R*,8S*,8aR*)-6-((1-(tert-butoxycarbonyl)-1H-indol-3-yl)methyl)-9-methoxy-5-
oxo-2,3,5,6,7,8-hexahydro-1H-6,8a-(azenometheno)indolizine-7,8-dicarboxylate. 
(14) 
To a flame-dried reaction flask under N2 was added BnOH (232 μL, 2.23 mmol) and THF 
(2 mL). The reaction vessel was then cooled to –78 °C, and a solution of n-BuLi (2.2 M in 
hexanes, 932 μL, 2.03 mmol) was added. The LiOBn solution was added dropwise via 
syringe to a second flask containing cycloadduct 11 (1.00 g, 2.03 mmol) in THF (17 mL) 
at –78 °C. The reaction was stirred at –78 °C for 30 min, diluted with 20 mL of sat’d NH4Cl, 
and extracted with CH2Cl2 (4 X 25 mL). The combined organic layers were washed with 
sat’d aq NaHCO3, sat’d aq NaCl (100 mL), dried with anhydrous Na2SO4, filtered, and 
concentrated in vacuo. The resulting solid was dissolved in PhMe (20 mL) and cooled to 
0 °C and a solution of TMS-diazomethane (2M in hexanes, 1.22 mL, 2.44 mmol) and 
MeOH (2 mL), were added. The reaction was stirred at 0 °C for 30 min before another 
portion of TMS-diazaomethane (2M in hexanes, 0.61 mL, 1.22 mmol) was added, and the 
reaction stirred at 0 °C for an additional 30 min. The reaction was concentrated in vacuo 
to afford a mix of compounds 13 and 14 in a 6:1 ratio (as judged by the unpurified 1H-
NMR). The reaction mixture was purified by flash column chromatography on silica gel 
(gradient elution: 20% → 100% EtOAc in hexanes) to afford pure 13 (599 mg, 48% yield) 
and 14 (186 mg, 15% yield) as amorphous solids. The strucutre of products 13 and 14 
were validated using HSQC and HMBC NMR correlations: 13 TLC (60% EtOAc in 
hexanes) Rf: 0.49 (UV, CAM); IR (film, cm-1) 2972, 1779, 1726, 1680, 1636, 1451, 1369, 
1310, 1256, 1155, 1082, 949, 733; 1H NMR (400 MHz, CDCl3) δ 8.06 (d, J= 7.4 Hz, 1H), 
7.76 (s, 1H), 7.74 (d, 1H), 7.34 (m, 5H), 7.21 (m, 2H), 5.06 (d, J= 12.1 Hz, 1H), 4.99 (d, 
J= 12.1 Hz, 1H), 3.75 (s, 3H), 3.53 (d, J= 14.4 Hz, 1H), 3.49 (d, J= 11.0 Hz, 1H), 3.45 (m, 
1H), 3.29 (d, 1H), 3.28 (m, 1H), 3.27 (s, 3H), 3.21 (d, J= 11 Hz, 1H), 2,82 (m, 1H), 1.92 
(m, 3H), 1.63 (s, 9H); 13C NMR (400 MHz, CDCl3) δ 170.0, 169.4, 169.2, 132.1, 132.0, 
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131.9, 128.6, 128.4, 126.0, 123.6, 121.9, 120.4, 116.2, 114.7, 68.5, 67.1, 64.9, 54.8, 53.9, 
51.6, 49.6, 43.5, 28.9, 28.2, 27.4, 24; exact mass calc’d for C34H38N308 [M + H]+ 616.2653, 
found 616.2646. 14: TLC (80% EtOAc in hexanes) Rf: 0.59 (UV, CAM); 1H NMR (400 
MHz, CDCl3) δ 8.07 (d, J= 6.9 Hz, 1H), 7.74 (s, 1H), 7.69 (d, J= 7.9 Hz, 1H), 7.25 (m, 7H), 
5.01 (d, J= 12.1 Hz, 1H), 4.72 (d, J= 12.5 Hz, 1H), 3.76 (s, 3H), 3.56 (d, J= 14.8 Hz, 1H), 
3.54 (d, J= 11.1 Hz, 1H), 3.45 (m, 1H), 3.38 (s, 3H), 3.29 (m, 1H), 3.25 (d, J= 14.8 Hz, 
1H), 3.17 (d, J= 11.1 Hz, 1H), 2.83 (m, 1H), 1.92 (m, 3H), 1.63 (s, 9H) ; 13C NMR (400 
MHz, CDCl3) δ 170.2, 170.0, 169.7, 169.1, 149.9, 135.1, 132.2, 128.5, 128.4, 126.0, 123.6, 
121.9, 120.6, 116.2, 114.7, 83.0, 68.5, 66.9, 64.9, 54.9, 53.6, 51.8, 49.9, 43.5, 28.8, 28.2, 
27.4, 24.5.  
 
8-Benzyl 7-methyl (6S*,7R*,8S*,8aS*)-6-((1-(tert-butoxycarbonyl)-1H-indol-3-
yl)methyl)-5,9-dioxohexahydro-1H-6,8a-(epiminomethano)indolizine-7,8-
dicarboxylate. (15) 
A dry reaction flask was charged with lactim ether 13 (261 mg, 0.424 mmol) and flushed 
with N2 gas for 10 min, dissolved in CH2Cl2 (2.1 mL), and cooled to 0 °C. To the reaction 
flask was added pTsOH·H2O (85 mg, 0.446 mmol), and the reaction was stirred for 7 h at 
0 °C. The reaction mixture was diluted with sat’d aq NaHCO3 (10 mL) and extracted with 
CH2Cl2 (4 X 10 mL). The combined organic layers were washed with sat’d aq NaCl (40 
mL), dried with anhydrous Na2SO4, filtered, and concentrated in vacuo. The resulting 
product was dissolved in toluene (2.1 mL) and stirred at 80 °C for 18 h. The solution was 
concentrated in vacuo to afford lactam 15 as a white solid. The unpurified product was 
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purified by flash column chromatography on silica gel (gradient elution: 40% → 100% 
EtOAc in hexanes) to afford pure lactam 15 as a yellow oil (195 mg, 77% yield): TLC (60% 
EtOAc in hexanes) Rf: 0.47 (UV, CAM);    IR (film, cm-1) 2986, 2244, 1695, 1458, 1368, 
1257, 1153, 1079, 907, 726; 1H NMR (400 MHz, CDCl3) δ 8.11 (d, J= 7.9 Hz, 1H), 7.68 (s, 
1H), 7.66 (d, J= 3.6 Hz, 1H), 7.31 (m, 8H), 5.98 (s, 1H), 5.12 (d, J= 12.1 Hz, 1H), 5.08 (d, 
J= 12.1 Hz, 1H), 3.67 (d, J= 14.5 Hz, 1H), 3.56 (m, 1H), 3.44 (m, 1H), 3.40 (s, 3H), 3.35 
(d, J= 8.2 Hz, 1H), 3.33 (d, J= 14.5 Hz, 1H), 2.79 (m, 1H), 1.97 (m, 1H), 1.85 (m, 1H), 1.67 
(s, 9H); 13C NMR (400 MHz, CDCl3) δ 169.1, 169.0, 168.4, 167.2, 149.5, 135.1, 134.8, 
131.0, 128.7, 128.6, 126.9, 124.6, 122.9, 118.7, 115.3, 112.8, 83.7, 68.0, 67.5, 63.2, 52.4, 
51.9, 48.6, 44.4, 28.4, 28.2, 24.3, 23.4; MASS SPEC SAMPLE NEEDS TO BE 
SUBMITTED. 
 
(6S*,7R*,8S*,8aS*)-6-((1-(tert-butoxycarbonyl)-1H-indol-3-yl)methyl)-7-
(methoxycarbonyl)-5,9-dioxohexahydro-1H-6,8a-(epiminomethano)indolizine-8-
carboxylic acid. (16) 
Lactam 15 (364 mg, 0.607 mmol) was dissolved in EtOAc (6 mL) at rt, and 10% Pd/C (65 
mg) was added. One balloon of H2 gas was used to sparge the reaction mixture for 10 
min, and another balloon of H2 gas was left above the reaction to maintain an atmosphere 
of H2. The reaction mixture was stirred at rt for 1 h before the reaction mixture was filtered 
through Celite, and the filter pad was washed with EtOAc (3 X 10 mL). The filtered solution 
was then concentrated in vacuo to afford carboxylic acid 16 (285 mg, 92% yield) as a 
white solid that was used without further purification: TLC (5% MeOH in CHCl3 with 1% 
AcOH) Rf: 0.22 (UV, CAM); IR (film, cm-1) 3366, 2970, 2891, 1736, 1680, 1453, 1368, 
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1309, 1257, 1158, 1128, 1081, 949, 816, 747; 1H NMR (400 MHz, CDCl3) δ 8.10 (d, J= 
7.8 Hz, 1H), 7.69 (d, J= 7.4 Hz, 1H), 7.67 (s, 1H), 7.29 (m, 2H), 6.57 (s, 1H), 6.57 (s-broad, 
1H), 3.68 (d, J= 14.8 Hz, 1H), 3.65 (s, 3H), 3.51 (m, 2H), 3.45 (d, J= 14.5 Hz, 1H), 3.40 
(d, J= 11.3 Hz, 1H), 3.36 (d, J= 11.4 Hz, 1H), 2.77 (m, 1H), 2.00 (m, 3H), 1.67 (s, 9H); 13C 
NMR (400 MHz, CDCl3) δ 169.6, 167.3, 149.6, 135.1, 131.1, 126.9, 124.5, 122.8, 119.0, 
115.3, 113.0, 83.8, 68.2, 63.4, 52.6, 52.3, 48.4, 44.5, 28.3, 28.2, 24.3, 23.6; exact mass 
calc’d for C26H30N3O8 [M + H]+ 512.2027, found 512.2030. 
 
8-(1,3-dioxoisoindolin-2-yl) 7-methyl (6S*,7R*,8S*,8aS*)-6-((1-(tert-butoxycarbonyl)-
1H-indol-3-yl)methyl)-5,9-dioxohexahydro-1H-6,8a-(epiminomethano)indolizine-
7,8-dicarboxylate. (17) 
 A dry flask was charged with carboxylic acid 16 (100 mg, 0.196 mmol), flushed with N2 
gas for 10 min, dissolved in CH2Cl2 (4 mL), and cooled to 0°C. EDC (56 mg, 0.294 mmol), 
DMAP (5 mg, 0.039 mmol), and N-hydroxylphthalimide (48 mg, 0.294 mmol) were added 
to the flask as solids, and the reaction was stirred and allowed to warm to rt over 6 h. The 
reaction mixture was diluted with 0.1 M HCl (20 mL) and extracted with CH2Cl2 (3 X 15 
mL). The combined organic layers were washed with sat’d aq NaHCO3 (25 mL), sat’d aq 
NaCl (25 mL), dried over anhydrous Na2SO4, filtered, and concentrated in vacuo to afford 
phthalimidoyl ester 17 as a mixture containing excess N-hydroxyl phthalimide and EDC 
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by-products. The unpurified product was purified by flash column chromatography on silica 
gel (gradient elution: 10% → 80% EtOAc in hexanes) to afford pure 17 (104 mg, 80% 
yield) as a white solid: TLC (60% EtOAc in hexanes) Rf: 0.64 (UV, CAM); m.p. 162.4-
164.3 °C; IR (film, cm-1) 2971, 1814, 1784, 1743, 1700, 1452, 1369, 1257, 1155, 1080, 
1017, 977, 911, 877, 729, 695; 1H NMR (400 MHz, CDCl3) δ 8.14 (d, J= 7.8 Hz, 1H), 7.90 
(m, 2H), 7.83 (m, 2H), 7.69 (s, 1H), 7.59 (dd, J= 6.7 Hz, 1.2 Hz, 1H), 7.33 (td, J= 7.4 Hz, 
1.5 Hz, 1H), 7.29 (td, J= 7 Hz, 1.2 Hz, 1H), 5.96 (s, 1H), 3.88 (s, 3H), 3.78 (d, J= 14.8 Hz, 
1H), 3.60 (m, 1H), 3.56 (d, J= 5.9 Hz, 1H), 3.48 (m, 1H), 3.47 (d, J= 5.8 Hz, 1H), 3.29 (d, 
J= 14.8 Hz, 1H), 2.90 (ddd, J= 13.3 Hz, 7.9 Hz, 4.7 Hz, 1H), 2.42 (td, J= 14.1 Hz, 8.2 Hz, 
1H), 2.15 (m, 1H), 1.96 (m, 1H), 1.67 (s, 9H); 13C NMR (400 MHz, CDCl3) δ 170.0, 169.3, 
167.4, 166.3, 149.5, 135.2. 135.1, 134.2, 130.9, 128.7, 127.1, 124.7, 124.2, 123.4, 123.1, 
118.3, 115.5, 112.3, 83.9, 68.5, 63.6, 52.9, 50.7, 47.8, 45.1, 28.2, 26.6, 24.1, 23.2; exact 
mass calc’d for C34H33N4O10 [M + H]+ 657.2191, found 657.1828. 
 
Methyl (6S*,7R*,8aS*)-6-((1-(tert-butoxycarbonyl)-1H-indol-3-yl)methyl)-5,9-
dioxohexahydro-1H-6,8a-(epiminomethano)indolizine-7-carboxylate. (18) 
A flame-dried flask was charged with phthalimidoyl ester 17 (36 mg, 0.054 mmol), flushed 
with N2 gas for 10 min, and dissolved in CH3CN (1 mL). To the reaction vessel was added 
Hantzsch ester (15 mg, 0.059 mmol), AIBN (1 mg, 0.0054 mmol), and t-BuSH (30 μL, 
0.268 mmol), and the reaction vessel was fitted with a reflux condenser. The reaction was 
stirred and heated at 80 °C for 1 h. The reaction mixture was diluted with sat’d aq NaHCO3 
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(10 mL) and extracted with CH2Cl2 (3 X 10 mL). The combined organic layers were washed 
with sat’d aq NaCl (20 mL), dried over anhydrous Na2SO4, filtered, and concentrated in 
vacuo to give decarboxylated product 18. The product was purified by flash column 
chromatography on silica gel (gradient elution: 20% → 100% EtOAc in hexanes) to afford 
pure 18 (15 mg, 60% yield) as a colorless oil. The structure of 18 was validated by 
comparison to known material: TLC (80% EtOAc in hexanes) Rf: 0.46 (UV, CAM); IR (film, 
cm-1) 2978, 1786, 1745, 1733, 1452, 1370, 1256, 1159, 1084; 1H NMR (400 MHz, CDCl3) 
δ 8.13 (d, J= 7.9 Hz, 1H), 7.64 (s, 1H), 7.57 (dd, J= 7.1 Hz, 1.2 Hz, 1H), 7.32 (td, J= 7.1 
Hz, 1.2 Hz, 1H), 7.27 (td, J= 7.4 Hz, 1.2 Hz, 1H), 5.83 (s, 1H), 3.76 (s, 3H), 3.70 (d, J= 
14.9 Hz, 1H), 3.51 (d, J= 15.2 Hz, 1H), 3.51 (m, 1H), 3.15 (d, J= 14.9 Hz, 1H), 3.05 (dd, 
J= 10.4 Hz, 4.9 Hz, 1H), 2.73 (dt, J= 13.3 Hz, 6.7 Hz, 1H), 2.28 (dd, J= 13.5 Hz, 10.3 Hz, 
1H), 2.18 (dd, J= 13.7 Hz, 5.1 Hz, 1H), 2.00 (m, J= 7.0 Hz, 2H), 1.80 (dt, J= 13.3 Hz, 7.0 
Hz, 1H), 1.67 (s, 9H);13C NMR (400 MHz, CDCl3) δ 171.9, 171.6, 167.2, 131.0, 126.8, 
124.7, 123.0, 118.3, 115.5, 112.9, 83.8, 66.7, 63.9, 53.4, 52.3, 46.0, 44.3, 36.1, 28.9, 28.2, 
24.3, 23.5; exact mass calc’d for C25H30N3O6 [M + H]+ 468.2129, found 468.2127. 
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